Saltar al contenido
Merck

A novel class of potent NF-kappaB signaling inhibitors.

Bioorganic & medicinal chemistry letters (2007-09-18)
Johann Leban, Marcel Baierl, Jan Mies, Viola Trentinaglia, Sandra Rath, Kerstin Kronthaler, Kristina Wolf, Astrid Gotschlich, Markus H J Seifert
RESUMEN

A novel class of NF-kappaB pathway signaling inhibitors was discovered by virtual screening, medicinal chemistry, and QSAR analysis. An initial set of compounds inhibited NF-kappaB signaling in a whole cell reporter gene assay in the micro-molar range. Activity was improved step by step by medicinal chemistry to yield nano-molar signaling inhibitors.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
SC75741, ≥97% (HPLC)